Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
4.2K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicopathological and genomic analysis of SWI/SNF chromatin remodeling abnormalities with a focus on SMARCA4 in cancer of unknown primary.

Journal of cancer research and clinical oncologyยท2025
Same author

Time-series clustering of the migration speed of nucleolus-precursor bodies in human zygotes and live birth following assisted reproductive technology.

Journal of assisted reproduction and geneticsยท2025
Same author

The relationship between controlled ovarian stimulation protocol, meiotic spindle visibility, position of the meiotic spindle relative to the polar body in the human oocyte, and clinical outcomes following ICSI.

Reproductive medicine and biologyยท2024
Same author

A hyaluronic acid-containing reagent compatible with glass-bottom dishes and capable of sustained binding of human spermatozoa.

Andrologyยท2024
Same author

Evaluating Factor VIII Concentrates Using Clot Waveform Analysis.

Journal of clinical medicineยท2024
Same author

The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate.

Journal of clinical medicineยท2023

Related Experiment Video

Updated: Mar 22, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.4K

[Hypercoagulable State in Cancer].

Yoshiki Yamashita

    Rinsho Byori. the Japanese Journal of Clinical Pathology
    |April 20, 2016
    PubMed
    Summary

    Cancer patients face a significantly higher risk of venous thromboembolism (VTE). The Khorana Risk Score helps stratify this risk, aiding in VTE prevention strategies for cancer patients.

    Area of Science:

    • Oncology
    • Hematology
    • Thrombosis Research

    Context:

    • Cancer patients exhibit a 4-7 times higher risk of venous thromboembolism (VTE) compared to the general population.
    • The prothrombotic state in cancer arises from complex interactions between tumor, patient factors, and the coagulation system.
    • Understanding the pathophysiology of cancer-associated thrombosis is crucial for effective management.

    Purpose:

    • To elucidate the multifactorial pathophysiology of cancer-associated thrombosis.
    • To identify key risk factors and predictive biomarkers for VTE in cancer patients.
    • To evaluate the utility of risk stratification tools like the Khorana Risk Score.

    Summary:

    • Cancer-associated thrombosis involves intricate mechanisms including cancer cells, host cells, coagulation factors, tissue factor (TF), inflammatory cytokines, and platelets.

    More Related Videos

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
    04:37

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

    Published on: May 23, 2025

    1.2K
    Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
    04:56

    Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

    Published on: August 4, 2023

    1.3K

    Related Experiment Videos

    Last Updated: Mar 22, 2026

    Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
    04:40

    Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

    Published on: January 5, 2024

    3.4K
    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
    04:37

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

    Published on: May 23, 2025

    1.2K
    Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
    04:56

    Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

    Published on: August 4, 2023

    1.3K
  • Biomarkers such as elevated leukocyte and platelet counts, low hemoglobin, and fibrinolytic markers (FRMs) are predictive of VTE.
  • The Khorana Risk Score effectively stratifies cancer patients into low, intermediate, and high VTE risk categories, validated by studies like the Vienna CATS study.

    • Impact:

    • Improved risk stratification for venous thromboembolism (VTE) in cancer patients.
    • Potential for enhanced VTE prevention strategies tailored to individual risk levels.
    • Advances in understanding the complex interplay of factors contributing to thrombosis in malignancy.